RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

Mortality was higher in the RSV cohort, with a 10.1% death rate, compared to 5.5% for flu. RSV infection showed a 52% higher ...

This builds upon its initial approval in May 2024 for adults aged 60 years and older, which makes mRESVIA the second approved ...

The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial ...

The CDC's vaccine advisory committee is set to meet for the first time since HHS Secretary Robert F. Kennedy Jr. dismissed ...

Shilajit, a Himalayan substance used in Ayurvedic medicine, offers antioxidant and anti-inflammatory benefits. Studies ...

On Wednesday, the eight new members of the CDC’s Advisory Committee on Immunization Practices will begin a 2-day meeting in ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.

A prominent paediatrician on Sunday urged people to take more precautions against a common virus known as RSV, saying cases ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated ...

This resource details recent developments in vaccinations, how addressing misinformation and hesitancy can improve public health, updated vaccination guidelines and more.

La., has come out critical of Robert F. | Sen. Bill Cassidy, M.D., R-La., has come out critical of Robert F. Kennedy Jr.’s ...